APA (7th ed.) Citation

A, C., N, L., P, M., P, R., E, S., F, V., . . . O, K. (2025). Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade. Translational oncology, 59, 102464. https://doi.org/10.1016/j.tranon.2025.102464

Chicago Style (17th ed.) Citation

A, Constantinides, et al. "Treatment of Colorectal Peritoneal Metastases with Oxaliplatin Induces Biomarkers Predicting Response to Immune Checkpoint Blockade." Translational Oncology 59 (2025): 102464. https://doi.org/10.1016/j.tranon.2025.102464.

MLA (9th ed.) Citation

A, Constantinides, et al. "Treatment of Colorectal Peritoneal Metastases with Oxaliplatin Induces Biomarkers Predicting Response to Immune Checkpoint Blockade." Translational Oncology, vol. 59, 2025, p. 102464, https://doi.org/10.1016/j.tranon.2025.102464.